Physitrack PLC
STO:PTRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Physitrack PLC
STO:PTRK
|
UK |
|
A
|
AroCell AB (publ)
STO:AROC
|
SE |
Balance Sheet
Balance Sheet Decomposition
Physitrack PLC
Physitrack PLC
Balance Sheet
Physitrack PLC
| Nov-2018 | Nov-2019 | Nov-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
13
|
1
|
1
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
1
|
13
|
1
|
1
|
1
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
3
|
3
|
3
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
2
|
3
|
2
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Assets |
0
|
0
|
2
|
15
|
4
|
4
|
4
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
2
|
2
|
2
|
3
|
10
|
10
|
8
|
6
|
|
| Goodwill |
0
|
0
|
6
|
14
|
27
|
24
|
18
|
11
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
6
|
14
|
27
|
24
|
18
|
11
|
|
| Total Assets |
2
N/A
|
2
-10%
|
10
+423%
|
32
+239%
|
41
+28%
|
38
-8%
|
31
-20%
|
19
-37%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
4
|
4
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
2
|
5
|
3
|
2
|
3
|
|
| Total Current Liabilities |
1
|
1
|
4
|
4
|
7
|
6
|
5
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
4
|
5
|
4
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
5
|
10
|
3
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-5%
|
4
+437%
|
9
+112%
|
19
+111%
|
13
-31%
|
11
-13%
|
9
-19%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
2
|
1
|
2
|
2
|
1
|
5
|
14
|
|
| Additional Paid In Capital |
3
|
3
|
5
|
25
|
25
|
25
|
25
|
25
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Equity |
1
N/A
|
1
-13%
|
5
+412%
|
23
+342%
|
22
-4%
|
25
+12%
|
19
-24%
|
10
-48%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-10%
|
10
+423%
|
32
+239%
|
41
+28%
|
38
-8%
|
31
-20%
|
19
-37%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
16
|
16
|
0
|
16
|
16
|
16
|
16
|
16
|
|